DFCM
RCKT icon

Dark Forest Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Dark Forest Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-153,814
Closed -$377K – 1428
2025
Q2 		$377K Buy
153,814
+140,795
+1,081% +$713K 0.02% 987
2025
Q1 		$86.8K Buy
+13,019
New +$129K ﹤0.01% 1178
2023
Q2 		– Sell
-4,790
Closed -$82.1K – 1332
2023
Q1 		$82.1K Buy
+4,790
New +$93.8K 0.02% 718
2022
Q3 		– Sell
-265
Closed -$4K – 1384
2022
Q2 		$4K Buy
+265
New +$3.16K ﹤0.01% 666
2022
Q1 		– Sell
-326
Closed -$7K – 1679
2021
Q4 		$7K Sell
326
-342
-51% -$9.33K ﹤0.01% 1063
2021
Q3 		$20K Buy
+668
New +$24.3K 0.01% 813

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Dark Forest Capital Management's RCKT Position: Q3 2025 in Review

Dark Forest Capital Management sold out of Rocket Pharmaceuticals (RCKT) in Q3 2025, closing a stake of 153,814 shares — an estimated $377K sold.

Dark Forest Capital Management first reported a position in RCKT in Q3 2021 and held it in 6 quarters. The position peaked at $377K in Q2 2025. 173 funds tracked by Wall St. Rank hold RCKT as of Q3 2025.

  • Dark Forest Capital Management reported no remaining Rocket Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 153,814 Rocket Pharmaceuticals shares in Q3 2025, an estimated $377K.
  • Dark Forest Capital Management first reported a position in Rocket Pharmaceuticals in Q3 2021 and held it in 6 quarters.
  • Dark Forest Capital Management's Rocket Pharmaceuticals position peaked at $377K in Q2 2025.
  • 173 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2025.

Based on Dark Forest Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.